These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3921418)

  • 1. Effects of 6-hydroxydopamine-induced catecholamine depletion on shock-precipitated wall climbing of infant rat pups.
    Emerich DF; Scalzo FM; Enters EK; Spear NE; Spear LP
    Dev Psychobiol; 1985 May; 18(3):215-27. PubMed ID: 3921418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ontogeny of phencyclidine-induced wall climbing and locomotor activity.
    Scalzo FM; Burge LJ
    Dev Psychobiol; 1992 Dec; 25(8):597-612. PubMed ID: 1487084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental and biologic interactions on behavior: effects of artificial rearing in rat pups treated with 6-hydroxydopamine.
    Goldenring JR; Shaywitz BA; Wool RS; Batter DK; Anderson GM; Cohen DJ
    Dev Psychobiol; 1982 Jul; 15(4):297-307. PubMed ID: 6809512
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine.
    Stockmeier CA; Larsen BR; Blask DE
    J Neurosci Res; 1985; 14(2):279-84. PubMed ID: 3930758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats.
    Boyce PJ; Finlay JM
    Brain Res Dev Brain Res; 2005 May; 156(2):167-75. PubMed ID: 16099303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholinergic influences on wall climbing and its ontogenetic decline.
    Linville DG; Spear LP
    Psychopharmacology (Berl); 1988; 95(2):200-7. PubMed ID: 3137598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term effects of intraventricular 6-hydroxydopamine in rats pretreated with a monoamine oxidase inhibitor.
    Vetulani J; Reichenberg K; Wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1977; 29(6):645-56. PubMed ID: 564059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfanilic acid: behavioral change related to azo food dyes in developing rats.
    Goldenring JR; Batter DK; Shaywitz BA
    Neurobehav Toxicol Teratol; 1982; 4(1):43-9. PubMed ID: 6803178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of central action of octopamine.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1979; 31(5):509-16. PubMed ID: 121158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 13. Open-field behavior in dopamine-depleted rat pups and their mothers.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1983 Feb; 18(2):285-7. PubMed ID: 6403951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
    Lytle LD; Shoemaker WJ; Cottman K; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Oct; 183(1):56-64. PubMed ID: 5080034
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.
    Smith RD; Cooper BR; Breese GR
    J Pharmacol Exp Ther; 1973 Jun; 185(3):609-19. PubMed ID: 4145870
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
    Concannon JT; Braughler JM; Schechter MD
    Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of 6-hydroxydopamine on the autogenic motor activity of newborn rat pups].
    Bursian AV; Timofeeva OP
    Zh Evol Biokhim Fiziol; 1990; 26(1):92-7. PubMed ID: 2163145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological restructurings in the brain due to a decrease in the catecholamine level].
    Otellin VA; Kucherenko RP; Gilerovich EG; Usova IP; Fedosikhina LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):978-81. PubMed ID: 6089476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.